Zealand Pharma A-S Aktie

35,80 EUR +0,04 EUR +0,11 %

10:46:17

STU

32,20 CHF -0,22 CHF -0,67 %

10:47:39

BRX

Zealand Pharma A-S jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.2,55 Mrd. EUR

KGV5,09Div. Rendite0,00%

WKNA0YJW7

ISINDK0060257814

SymbolZLDPF

Zealand Pharma A-S Aktien News

Sortieren:Datum Meistgelesen

25.06.24GlobeNewswireZealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion

20.06.24GlobeNewswireZealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide

13.06.24GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

07.06.24GlobeNewswireZealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis

06.06.24GlobeNewswireZealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL

29.05.24GlobeNewswireZealand Pharma major shareholder announcement: Polar Capital

23.05.24GlobeNewswireZealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide

16.05.24GlobeNewswireZealand Pharma Announces Financial Results for the First Quarter of 2024

12.05.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

19.04.24GlobeNewswireCorrection to Company announcement – No. 23 / 2024

19.04.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

19.04.24GlobeNewswireZealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024

31.03.24GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at March 31, 2024

26.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

26.03.24GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

21.03.24GlobeNewswireZealand Pharma major shareholder announcement: Van Herk Investments

20.03.24GlobeNewswireZealand Pharma's Annual General Meeting 2024

19.03.24GlobeNewswireZealand Pharma major shareholder announcement: Polar Capital

19.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

13.03.24GlobeNewswireNew Employee Elected Directors to the Board of Zealand Pharma A/S

08.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

05.03.24GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

05.03.24GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

27.02.24GlobeNewswireZealand Pharma convenes its Annual General Meeting 2024

27.02.24GlobeNewswireZealand Pharma Announces Financial Results for the Full Year 2023

26.02.24GlobeNewswireZealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibro

31.01.24GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at January 31, 2024

26.01.24GlobeNewswireZealand Pharma major shareholder announcement: Van Herk Investments

19.01.24GlobeNewswireZealand Pharma major shareholder announcement: J O Hambro Capital Management

17.01.24GlobeNewswireZealand Pharma major shareholder announcement: J O Hambro Capital Management

12.01.24GlobeNewswireZealand Pharma completes registration of capital increase

10.01.24GlobeNewswireZealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

08.01.24GlobeNewswireZealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion

29.12.23GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at December 29, 2023

23.12.23GlobeNewswireU.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing

07.12.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

07.12.23GlobeNewswireZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

04.12.23GlobeNewswireTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

30.11.23GlobeNewswireTotal number of shares and voting rights in Zealand Pharma at November 30, 2023

30.11.23GlobeNewswireZealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers

Zealand Pharma A-S News

Zealand Pharma A-S News: auf dieser Seite finden Sie alle Zealand Pharma A-S News und Nachrichten zur Zealand Pharma A-S Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Zealand Pharma A-S News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Zealand Pharma A-S News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.